n-methyl-3,4-methylenedioxyamphetamine has been researched along with Alveolar Bone Atrophy in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breivik, T | 1 |
| Bogen, IL | 1 |
| Haug, KH | 1 |
| Fonnum, F | 1 |
| Opstad, PK | 1 |
| Eide, DM | 1 |
| Myhre, O | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Brain; Brain Chemistry; Disease Progression; Male; N-Methyl-3,4-methyle | 2014 |